Preoperative FOLFOX Appears Noninferior Vs CRT in Rectal Cancer
June 4th 2023“We think that we can successfully de-escalate treatment of rectal cancer and achieve the same high cure rates [and] keep patients disease free, with less long-term toxicity and effects,” lead author Deb Schrag, MD, FASCO, MPH, said.